Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
07/2002
07/25/2002WO2002057258A1 Cyclo`d!azepane derivatives which are used as farnesyltransferase inhibitors and method for the preparation thereof
07/25/2002WO2002057257A1 Cyclo`c!azepane derivatives which are used as farnesyltransferase inhibitors and method for the preparation therefor
07/25/2002WO2002057256A1 Piperazinylcarbonylquinolines and -isoquinolines
07/25/2002WO2002057254A1 Compositions for prevention or treatment of hepatopathy
07/25/2002WO2002057253A2 Isoindolyl and isoquinolinyl aroyl pyrrole compounds for the treatment of central nervous system disorders
07/25/2002WO2002057223A2 Compounds azepane, preparation method therefor and pharmaceutical compositions containing said compounds
07/25/2002WO2002056884A2 Treatment of malaria with farnesyl protein transferase inhibitors
07/25/2002WO2002056681A2 Novel intermediates and process to pyrimidinedione herbicides
07/25/2002WO2002042268A3 Ep4 receptor selective agonists in the treatment of osteoporosis
07/25/2002WO2002032422A3 Ep4 receptor inhibitors to treat rheumatoid arthritis
07/25/2002WO2002014320A3 Novel substituted diaryl azepine derivatives as integrin ligands
07/25/2002US20020099224 Hydrolysis of [R (R*, R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide
07/25/2002US20020099208 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
07/25/2002US20020099084 Pharmaceutically active compounds and methods of use
07/25/2002US20020099071 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
07/25/2002DE10130830A1 Indol-Derivate Indole derivatives
07/25/2002CA2435141A1 Compositions for prevention or treatment of hepatopathy
07/25/2002CA2432776A1 Isoindolyl and isoquinolinyl aroyl pyrrole compounds
07/24/2002EP1224932A1 Drugs inhibiting cell death
07/24/2002EP1224183A2 Heterocyclic sodium/proton exchange inhibitors and method
07/24/2002EP1224181A1 Substituted pyrroles as antiproliferative agents for the treatment of cancer
07/24/2002EP1224180A2 Substituted azoles
07/24/2002EP1224175A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
07/24/2002EP1224174A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
07/24/2002EP1224171A1 Beta disubstituted metalloprotease inhibitors
07/24/2002EP1224170A1 6-position substituted indoline, production and use thereof as a medicament
07/24/2002EP1224169A2 Production of 5-substituted indolinones and use thereof as medicaments
07/24/2002EP1223933A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
07/24/2002EP1223932A1 Compounds and methods
07/24/2002EP1223921A2 Tissue factor antagonists and methods of use thereof
07/24/2002EP0859759B1 Sulphonic acids and their use as u/v absorbers
07/24/2002EP0684945B1 Pyrazole- or isoxazole-substituted alkyl amide acat inhibitors
07/24/2002CN1360583A Novel compounds, their use and preparation
07/24/2002CN1360582A Quinazoline derivs.
07/24/2002CN1360502A Use of dopamine D3 receptor ligands for producing medicaments for treating kidney disorders
07/24/2002CN1088063C Sulfmidyl (thio) carbonyl-1,2,4-triazolineone deriv. and preparation method and application as weed killer
07/24/2002CN1088062C Certain 4-aminomethy-2-substd. imidazole derivs. and 2-aminomethyl-4-substd. imidazole derivs. new classes of dopamine receptor subtype specific ligands
07/23/2002US6423840 Forming n-acylamino compound
07/23/2002US6423729 Therapeutic or prophylactic agent for glomerulopathy
07/23/2002US6423716 Nitrogenous heterocyclic compounds
07/23/2002US6423713 Substituted pyrazoles as p38 kinase inhibitors
07/23/2002US6423710 Cyclic AMP-specific phosphodiesterase inhibitors
07/23/2002US6423704 Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
07/23/2002CA2107675C Antibiotic carbapenem derivatives
07/23/2002CA2102180C Novel immunosuppressive pyrrolidine/piperidine/azepane-2-carboxylic acid derivatives
07/18/2002WO2002055518A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists
07/18/2002WO2002055517A2 4-(hetero)aryl substituted indolinones
07/18/2002WO2002055492A2 An improved process for preparing pure ondansetron hydrochloride dihydrate
07/18/2002WO2002040455A8 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars)
07/18/2002WO2002024661A3 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
07/18/2002WO2001090103A3 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
07/18/2002WO2001072728A3 Novel piperazine derivatives
07/18/2002WO2001056974A3 Inha inhibitors and their use as antibacterials
07/18/2002US20020095044 Substituted isoindolinone derivatives
07/18/2002US20020094998 Methods and compositions for treatment of ocular neovascularization and neural injury
07/18/2002US20020094994 Pyrrolidine carboxylic Acid or ester derivatives are useful for treating alpha 4 beta 1 mediated cell adhesion
07/18/2002US20020094989 Pyrrolidine modulators of CCR5 chemokine receptor activity
07/18/2002US20020094987 Amide or thioamide substituted benzimidazole or quinoxaline derivatives; therapeutic utility via inhibition of tumor necrosis factor or phosphodiesterase
07/18/2002DE10102053A1 Piperazinylcarbonyl-quinoline and piperazinylcarbonyl-isoquinoline derivatives useful for treatment of e.g. schizophrenia, psychoses, depression, Parkinson's disease and Alzheimer's disease
07/18/2002CA2433720A1 An improved process for preparing pure ondansetron hydrochloride dihydrate
07/18/2002CA2433084A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists
07/18/2002CA2432114A1 4-(hetero)aryl substituted indolinones
07/17/2002EP1223170A1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof
07/17/2002EP1222185A1 Tetrahydrobenzindolone derivatives, their preparation and their use as 5-ht7 receptor antagonists
07/17/2002EP1222177A1 Substituted aryl ketones
07/17/2002EP1222175A1 4,5-disubstituted-2-aminopyrimidines
07/17/2002EP1222174A1 Imidazol-4-ylmethanols used as inhibitors of steroid c17-20 lyase
07/17/2002EP0888340B1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists
07/17/2002CN1359375A Novel piperazinylalkyl thiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of same
07/17/2002CN1359303A Pharmaceutical complex
07/17/2002CN1358718A Preparation for 2-(1H-1,2,4-pyrrodiazole-1) imidazolinone derivant and bactericidal activity
07/17/2002CN1087741C New indole and inidazole compounds, process for their preparation and pharmaceutical compositions containing them
07/17/2002CN1087740C New benzimidzole, benzoxazole and benzothiazole compounds, process for their preparation and pharmaceutical compositions containing them
07/16/2002US6420563 Inverse antagonist
07/16/2002US6420560 H1—histamine receptor antagonists
07/16/2002US6420558 Aminopiperidine derivates as integrin αvβ3 antagonists
07/16/2002US6420555 Imidazolyl derivatives
07/16/2002US6420415 Thiol compounds, their production and use
07/16/2002US6420414 Amino derivatives of EM-138 and methods of treating angiogenesis with same
07/16/2002US6420390 Heteroarylpiperidines and their use as antipsychotics
07/16/2002US6420364 Treating autoimmune diseases,alzheimer's disease, atherosclerosis, osteoporosis,
07/16/2002US6420316 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
07/16/2002CA2205998C Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
07/16/2002CA2059704C [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives
07/11/2002WO2002053558A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
07/11/2002WO2002053557A1 Novel sulfamides and their use as endothelin receptor antagonists
07/11/2002WO2002053547A1 Alkanoic acid derivatives, process for their production and use thereof
07/11/2002WO2002053543A1 Pyridone derivative having affinity for cannabinoid 2-type receptor
07/11/2002WO2002053534A1 Vla-4 inhibitors
07/11/2002WO2002053155A1 Telomerase inhibitor
07/11/2002WO2002040507A3 Novel compounds for uses in radioimmunoscintigraphy and/or radioimmunotherapy of cancers
07/11/2002WO2002024658A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
07/11/2002WO2002008221A3 Capsaicin receptor ligands
07/11/2002US20020091262 Armoatic or heteroarmoatic compound containing substituted amides or thioamides
07/11/2002US20020091261 Phthalazines with angiogenesis inhibiting activity
07/11/2002US20020091260 Selective control of harmful plants in crops of useful plants
07/11/2002US20020091148 3-substituted indole antiproliferative angiogenesis inhibitors
07/11/2002US20020091127 Semicarbazides and their uses
07/11/2002US20020091119 Aralkyl and aralkylidene heterocyclic lactams and imides
07/11/2002US20020091118 Psychotherapeutic agents.